Rx-360 Engages The C=C Bond Group to Lead Business Development Activities

News provided by

Sep 08, 2015, 07:00 ET

WASHINGTON, September 8, 2015 /PRNewswire/ --

Rx-360 announced today it has formed a collaboration with The C=C Bond Group to help expand adoption of its audit program and develop other revenue generating activities. The C=C Bond Group, led by Scott Watson, will be promoting Rx-360 and growing the user base of its audit program.

"In the US, EU and in a growing number of countries, Pharmaceutical companies are legally required to audit their supplier of Active Pharmaceutical Ingredient (API) at least every 3 years. Some API producers are now the object of audits to an untenable frequency. The only solution going forward is for the sharing of audit reports by pharmaceutical companies to become the new normal. Rx-360 is the leading organization offering this service globally. We are counting on C=C Bond to communicate the savings that sharing audit reports provide to the entire supply chain. Scott Watson has long been associated with Rx-360, first as Membership Committee Chairman, and then as a Board Member. We believe his group has the energy, enthusiasm and contacts to help us significantly grow the audit program," stated Guy Villax, CEO of Hovione and the Chairman of Rx-360.

"I have strongly believed in the mission of Rx-360 since the organization was formed - to protect patient safety and to ensure authenticity and quality of materials as they move through the drug supply chain," stated Scott Watson, Principal, The C=C Bond Group.

The Rx-360 audit program is a key element toward achieving its mission. The program allows companies to leverage their ever scarce resources to focus audits on the most critical and higher risk suppliers, while using a licensed audit to effectively monitor other suppliers, maintain compliance and augment their internal efforts.

In June, 2014, Rx-360 announced their partnership with BSI (British Standards Institution) as the sole provider of all of Rx-360 audit services. Adding Scott and the C=C Bond team to this partnership gives the audit program the additional industry experience, leadership and visibility it needs to grow and succeed further.

"We are excited to help expand awareness of this terrific program and to be affiliated with Rx-360 in this way," concluded Watson.

About Rx-360:

Rx-360, an international pharmaceutical supply chain consortium, was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain. The organization's mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain. To fulfill this mission, Rx-360 has workstreams related to: conduction and sharing of audits, supply chain security, monitoring and reporting, Asia-focused efforts, supplier-focused efforts, and external relations, communications, and membership. To learn more about Rx-360, please visit http://www.Rx-360.org or email [email protected].

About The C=C Bond Group:

The C=C Bond Group, founded by Scott Watson, CFA, provides strategic and tactical advisory services to the pharmaceutical, biotechnology, chemicals and other industries. The founder has more than 25 years of experience in business and corporate development, operations, and sales. To learn more about The C=C Bond Group, please visit http://www.ccbondgroup.com/ or email us here.

Contact: Dede Godstrey | +1-202-230-5607 | [email protected]

SOURCE Rx-360